Ropes & Gray represented Cullinan Oncology in the deal.Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan Pearl. …
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
